Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Levente Bodoki

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Ocular Immunology and Inflammation|November 17, 2018
Corneal Involvement of Patients with Polymyositis and DermatomyositisZoltan Griger, Katalin Danko, Levente Bodoki, et al.
International Journal of Ophthalmology|September 21, 2020
Anterior segment parameters associated with extramuscular manifestations in polymyositis and dermatomyositisZoltan Griger, Katalin Danko, Gabor Nemeth, et al.
Frontiers in Oncology|November 2, 2023
Immune-related adverse events of anti-PD-1 immune checkpoint inhibitors: a single center experienceEnikő Sebestyén, Nóra Major, Levente Bodoki, et al.
Rheumatology International|December 19, 2019
Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitisEdit Végh, György Kerekes, Anita Pusztai, et al.
Orvosi Hetilap|July 2, 2020
Oncorheumatology: relationship between malignancies and musculoskeletal diseasesZoltán Szekanecz, Izabella Gomez, Boglárka Soós, et al.
Autoimmunity Reviews|September 17, 2020
Eight pillars of oncorheumatology: Crossroads between malignancies and musculoskeletal diseasesZoltán Szekanecz, Izabella Gomez, Boglárka Soós, et al.
Biomolecules|May 27, 2026
Clinical Relevance and Methodological Comparison of Anti-MDA5 Antibody Detection: A Five-Year Retrospective and Exploratory Pilot StudySándor Mogyoróssy, Gábor Nagy, Zoltán Griger, et al.
Clinical Rheumatology|September 16, 2019
Effects of 1-year anti-TNF-α therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitisKatalin Gulyás, Ágnes Horváth, Edit Végh, et al.
Biomolecules|October 27, 2022
Effects of One-Year Tofacitinib Therapy on Lipids and Adipokines in Association with Vascular Pathophysiology in Rheumatoid ArthritisMonika Czókolyová, Attila Hamar, Anita Pusztai, et al.
The Journal of Rheumatology|December 16, 2020
Soluble Vascular Biomarkers in Rheumatoid Arthritis and Ankylosing Spondylitis: Effects of 1-year Antitumor Necrosis Factor-α TherapyAnita Pusztai, Attila Hamar, Ágnes Horváth, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Ocular Immunology and Inflammation|November 17, 2018
Corneal Involvement of Patients with Polymyositis and DermatomyositisZoltan Griger, Katalin Danko, Levente Bodoki, et al.
International Journal of Ophthalmology|September 21, 2020
Anterior segment parameters associated with extramuscular manifestations in polymyositis and dermatomyositisZoltan Griger, Katalin Danko, Gabor Nemeth, et al.
Frontiers in Oncology|November 2, 2023
Immune-related adverse events of anti-PD-1 immune checkpoint inhibitors: a single center experienceEnikő Sebestyén, Nóra Major, Levente Bodoki, et al.
Rheumatology International|December 19, 2019
Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitisEdit Végh, György Kerekes, Anita Pusztai, et al.
Orvosi Hetilap|July 2, 2020
Oncorheumatology: relationship between malignancies and musculoskeletal diseasesZoltán Szekanecz, Izabella Gomez, Boglárka Soós, et al.
Autoimmunity Reviews|September 17, 2020
Eight pillars of oncorheumatology: Crossroads between malignancies and musculoskeletal diseasesZoltán Szekanecz, Izabella Gomez, Boglárka Soós, et al.
Biomolecules|May 27, 2026
Clinical Relevance and Methodological Comparison of Anti-MDA5 Antibody Detection: A Five-Year Retrospective and Exploratory Pilot StudySándor Mogyoróssy, Gábor Nagy, Zoltán Griger, et al.
Clinical Rheumatology|September 16, 2019
Effects of 1-year anti-TNF-α therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitisKatalin Gulyás, Ágnes Horváth, Edit Végh, et al.
Biomolecules|October 27, 2022
Effects of One-Year Tofacitinib Therapy on Lipids and Adipokines in Association with Vascular Pathophysiology in Rheumatoid ArthritisMonika Czókolyová, Attila Hamar, Anita Pusztai, et al.
The Journal of Rheumatology|December 16, 2020
Soluble Vascular Biomarkers in Rheumatoid Arthritis and Ankylosing Spondylitis: Effects of 1-year Antitumor Necrosis Factor-α TherapyAnita Pusztai, Attila Hamar, Ágnes Horváth, et al.
Pageof 4